The surgical repair of refractory ocular surface diseases using amniotic membrane.

Not Applicable

Recruiting

• Conditions: corneal perforations, glaucoma, Recurrent pterygium

• Registration Number: JPRN-UMIN000002983
• Lead Sponsor: Toyama University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2004-11-30
• Study Start: 2010-01-12
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

Not provided

Exclusion Criteria

Acute obvious ocular infectious signs are excluded. Exp. 1)Acute phase of bacterial, mycotic, or viral corneal ulcers 2)Acute phase of infectious bleb <recurrence pterygium> 1) onset pterygium patient or pseudopterygium patients. 2)The patients whom a doctor judged safely for 2) study period if it was difficult hospital visiting and to come home. 3)The patients who complicate eye infection with 3) activity. 4)The patients who plan the enforcement of eye operations for evaluation eyes effective during 4) study period in (we assume the agreement acquisition study initiation). 5)one eyes are the patients of enucleation eyes or evisceration eyes. 6)For the group medicine of the planned drug (dropping lotion in the eyes anesthetic agent, fluorescein) to use during 6) study period, it is the patients with a history of the drug allergy. 7)The patients (saying that, however, the subjects who do not receive the study drug are possible) who participated in other studies or clinical studies within six months. 8)The patients whom a doctor judged as an object of this study in testing at pregnancy or 9 childbearing patients) agreement acquisition that we might be pregnant or hoped for pregnancy during study period or did not use appropriate contraception for if inadequate.

Study & Design

• Study Type: Interventional
• Study Design: Not specified